Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NSE/POLYMED stock hub

NSE/POLYMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/POLYMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

167.4B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/POLYMED

In the news

Latest news · NSE/POLYMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E43.6

P25 24.9P50 32.4P75 45.7

Trailing P/E48.1

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC12.8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/POLYMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

INR

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	3,082
Employees Change	-3,218%
Employees Change Percent	-51.08
Enterprise value	INR 158.9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	INE205C01021
Last refreshed	2026-05-10
Market cap	INR 167.4B
Price	INR 1,650
Price currency	INR
Rev Per Employee	5,780,584.04x
Sector	Healthcare
Sic	3841
Symbol	nse/POLYMED
Website	https://www.polymedicure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.08%
EV Earnings	45.71x
EV/EBIT	44.06x
EV/EBITDA	34.75x
EV/Sales	8.92x
Forward P/E	43.64x
P/B ratio	5.71x
P/E ratio	48.14x
P/S ratio	9.39x
PE Ratio10 Y	41.7x
PE Ratio3 Y	61.98x
PE Ratio5 Y	60.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.9%
EBITDA Margin	25.22%
Gross margin	68%
Gross Profit	INR 12.1B
Gross Profit Growth	13.8%
Gross Profit Growth Q	21.68%
Gross Profit Growth3 Y	22.41%
Gross Profit Growth5 Y	19.28%
Net Income	INR 3.5B
Net Income Growth	10.35%
Net Income Growth Q	-16.78%
Net Income Growth Years	6%
Net Income Growth3 Y	30.45%
Net Income Growth5 Y	23.77%
Pretax Margin	26.11%
Profit Margin	19.52%
Profit Per Employee	INR 1.1M
Profitable Years	20
Roa5y	9.43
Roe5y	16.82
ROIC	12.76
Roic5y	17.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	28.95%
Cagr1y	-41.74%
Cagr3y	19.39%
Cagr5y	10.87%
Div CAGR10	8.84%
Div CAGR3	5.27%
Div CAGR5	6.96%
EPS Growth	5.46
EPS Growth Q	-17.57
EPS Growth Years	6
EPS Growth3 Y	27.89
EPS Growth5 Y	20.26
Revenue Growth	10.86x
Revenue Growth Q	16.37x
Revenue Growth Quarters	23x
Revenue Growth Years	19x
Revenue Growth3 Y	18.68x
Revenue Growth5 Y	19.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 11B
Debt	INR 2.4B
Debt EBITDA	INR 0.53
Debt Equity	INR 0.08
Equity	INR 29.3B
Interest Coverage	25.79
Net Cash	INR 8.6B
Net Cash By Market Cap	INR 5.12
Net Cash Growth	-21.43%
Net Debt EBITDA	INR -1.91
Net Debt Equity	INR -0.29
Tangible Book Value	INR 26.3B
Tangible Book Value Per Share	INR 260
WACC	4.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.61%
Dividend Growth	16.67%
Dividend Growth Years	1%
Dividend per share	INR 3.5
Dividend Years	21
Dividend Yield	0.23%
Ex Div Date	2025-09-18
Last Dividend	INR 3.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,171.06%
1Y total return	-41.72%
200-day SMA	1,734.9
3Y total return	70.21%
50-day SMA	1,381.3
50-day SMA vs 200-day SMA	50under200
5Y total return	67.54%
All Time High	3,357.8
All Time High Change	-50.88%
All Time High Date	2024-11-01
All Time Low	22.64
All Time Low Change	7,186.42%
All Time Low Date	2011-12-21
ATR	56.27
Beta	0.13
Ch YTD	-7
High	1,684.9
High52	2,830
High52 Date	2025-05-08
High52ch	-43.85%
Low	1,648
Low52	1,182
Low52 Date	2026-03-30
Low52ch	39.55%
Ma50ch	19.42%
Price vs 200-day SMA	-4.92%
RSI	69.2
RSI Monthly	47.25
RSI Weekly	53.34
Sharpe ratio	-0.91x
Sortino ratio	-1.21
Total Return	-4.38%
Tr YTD	-7
Tr1m	18.67%
Tr1w	7.97%
Tr3m	18.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.5B
Operating Income Growth	0.1
Operating Income Growth Q	-11.4
Operating Income Growth3 Y	24.88
Operating Income Growth5 Y	17.78
Operating margin	19.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,571,987%
Shares Insiders	39.71%
Shares Institutions	21.17%
Shares Qo Q	0.11%
Shares Yo Y	4.61%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	125,221.65x
Bv Per Share	287.9
Ch10y	1,117.3
Ch1m	18.67
Ch1w	7.97
Ch1y	-41.82
Ch3m	18.72
Ch3y	69.35
Ch5y	65.81
Ch6m	-12.9
Change	-1.81%
Change From Open	-2.1
Close	1,679.9
Days Gap	0.3
Depreciation Amortization	948,356,250
Dollar Volume	94,983,158.5
Earnings Date	2026-05-14
EBIT	INR 3.5B
EBITDA	INR 4.5B
EPS	INR 34.12
F Score	2
Fiscal Year End	March
Founded	1,995
Graham Number	472.04929
Graham Upside	-71.38
Income Tax	INR 1.2B
Is Primary Listing	0
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Date	2017-03-24
Last Split Type	Forward
Lynch Fair Value	INR 815
Lynch Upside	-50.61
Ma150	1,643.8
Ma150ch	0.35%
Ma20	1,512.6
Ma20ch	9.05%
Next Earnings Date	2026-05-14
Open	1,684.9
Payment Date	2025-10-25
Position In Range	4.07
Price Date	2026-05-08
Price EBITDA	INR 37.25
Ptbv Ratio	6.35
Relative Volume	0.44x
Revenue	17,815,760,000x
Tax By Revenue	6.6x
Tax Rate	25.28%
Tr6m	-12.9%
Volume	57,583

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/POLYMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$3.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.0%

1 consecutive years of growth

Total shareholder yield

-4.4%

Next ex-dividend date: 2025-09-18

Performance

NSE/POLYMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/POLYMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.2%

Share of float held by funds and institutions

Insider ownership

+39.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.6%

Negative means the company is buying back shares.

Technical

NSE/POLYMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.2

Neutral momentum band

Price vs 200-day MA

-4.9%

50/200-day relationship not available

Beta (5Y)

0.13

Less volatile than the market

Sharpe ratio

-0.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/POLYMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/POLYMED stock rating?

nse/POLYMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/POLYMED analysis?

The full report lives at /stocks/nse/POLYMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/POLYMED?

The latest report frames nse/POLYMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/POLYMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.